Latest articles by Phil Oakley
-
Gamble of the week: a throwback to the old days
Features There's a lot to like about the approach of this Midlands metal basher, says Phil Oakley.
Features -
What does IPO stand for? ‘It’s probably overpriced’
Tutorials Phil Oakley looks into the business of stock market flotations, and comes up with a reliable way to tell if it’s worth buying in.
Tutorials -
Get rich slowly with compounding
Tutorials The easiest way to get rich is to invest for the long term. And that means reinvesting your dividends, says Phil Oakley.
Tutorials -
Gamble of the week: A punt on Californian water
Tips This US-listed small-cap stock owns plenty of California farmland, says Phil Oakley. But it's what lies underneath that makes this share a punt.
Tips -
Shares in focus: A health check for Glaxo
Features There are lots of things to like about GlaxoSmithKline, but the giant pharma is also facing some big challenges, says Phil Oakley. So, should you buy the shares?
Features -
Why higher interest rates could be good news for BT
Features A rise in interest rates could deliver a nice boost to BT, one of Britain’s largest companies, says Phil Oakley. Here’s why.
Features -
How to manage investment risk
Tutorials To invest for a comfortable retirement, you need to manage the risks to your portfolio. Phil Oakley explains how.
Tutorials -
Gamble of the week: A competitive comparison site
Tips There's no shortage of price comparison sites to choose from, says Phil Oakley. But this one has an edge of its rivals.
Tips -
Shares in focus: Should you avoid the TSB float?
Tutorials High-street bank TSB is to be floated on the stock market. Should you snap up some shares? Phil Oakley investigates.
Tutorials -
How to value bank shares – and what this says about TSB
Features Phil Oakley explains how to tell how much a bank is worth, and whether you should buy TSB shares.
Features -
Gamble of the week: Royal Mail's plucky rival
Tips This independent parcel delivery service stands to profit from the growth of online shopping, says Phil Oakley.
Tips -
Shares in focus: Should you buy this specialist engineer?
Features British engineering firm IMI is a great business. Phil Oakley looks to see if now is a good time for investors to buy in.
Features -
Gamble of the week: A car dealer with growth potential
Tips Much of the easy money has already been made in car dealers, says Phil Oakley. But this is no ordinary car dealer.
Tips -
Shares in focus: Marston’s - time to get another round in?
Features Shares in pub brewer Marston's have been making steady progress. Phil Oakley looks to see if the shares are still worth buying.
Features -
Gamble of the week: Can this retailer return to profit?
Tips If this high-street retailer can rein in its losses, the shares could soar, says Phil Oakley.
Tips -
Shares in focus: A good time to be a landlord
Features Property company Segro has already rewarded investors, says Phil Oakley. Is there any value left in the shares?
Features -
Gamble of the week: struggling newspaper group
Tips Buying shares in struggling companies that can recover is a good investment strategy. And this newspaper group fits the bill nicely, says Phil Oakley.
Tips -
Saga: should you stay onshore for this stock market float?
Features For investors, will there be more rewarding trips than Saga can offer? Phil Oakley investigates.
Features -
Should you invest with top fund manager Neil Woodford?
Features Top fund manager Neil Woodford is set to launch his new fund having decided to strike out on his own. Phil Oakley reports.
Features -
How to cope with volatility in the markets
Tutorials While sometimes unpleasant, volatility is to be expected when investing in shares. Phil Oakley outlines some ways you can minimise the stress.
Tutorials -
Shares in focus: Can N Brown raise its game?
Features Clothes retailer N Brown Group has great prospects, but are the shares cheap enough to buy now? Phil Oakley investigates.
Features -
Company in the news: AstraZeneca
Features Drugs giant AstraZeneca is at the centre of a takeover tussle with US rival Pfizer. Phil Oakley looks at how the shares have been affected.
Features -
Shares in focus: Can Dairy Crest pull out of the doldrums?
Features Milk prices are falling, but Dairy Crest might have an ace up its sleeve. Should you buy the shares? Phil Oakley investigates.
Features -
Company in the news: Drax
Features Shares in Britain's biggest coal-fired power station, Drax, have fallen out of favour, says Phil Oakley.
Features
